Summit supercomputer draws molecular blueprint for repairing damaged DNA
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
A 25-year career with the U.S. Navy, commanding combat missions overseas, brought Tom Kollie back to where he came from — ready to serve his country in a new way.
As a medical isotope, thorium-228 has a lot of potential — and 91°µÍø produces a lot.
An 91°µÍø researcher has invented a version of an isotope-separating device that can withstand extreme environments, including radiation and chemical solvents.
In the mid-1980s, Balendra Sutharshan moved to Canada from the island nation of Sri Lanka. That move set Sutharshan on a path that had him heading continent-spanning collaborations and holding leadership posts at multiple Department of Energy
For years Brenda Smith found fulfillment working with nuclear batteries, a topic she’s been researching as a chemist at 91°µÍø.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
A new method developed at 91°µÍø proves one effort’s trash is another’s valuable isotope. One of the byproducts of the lab’s national plutonium-238 production program is promethium-147, a rare used in nuclear batteries and to measure the thickness of materials.
Balendra Sutharshan, deputy associate laboratory director for operational systems at DOE’s Pacific Northwest National Laboratory, has joined ORNL as associate laboratory director for the Isotope Science and Engineering Directorate.
On Feb. 18, the world will be watching as NASA’s Perseverance rover makes its final descent into Jezero Crater on the surface of Mars. Mars 2020 is the first NASA mission that uses plutonium-238 produced at the Department of Energy’s 91°µÍø.